Market Insights Health Pharmacies OTC Products

Analgesics (Pharmacies) - Japan

Japan

Revenue in the Analgesics market is projected to reach €0.46bn in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 5.46%, resulting in a market volume of €0.60bn by 2029.
In global comparison, most revenue will be generated in China (€4,614.00m in 2024).
In relation to total population figures, per person revenues of €3.77 are generated in 2024.

Key regions: China, South Korea, Canada, India, France

Mercado

Región

Comparación de regiones

Moneda

Analyst Opinion

The Analgesics (Pharmacies) market in Japan has been experiencing steady growth in recent years.

Customer preferences: Japanese consumers have a strong preference for over-the-counter analgesics for the treatment of common ailments such as headaches, muscle aches, and menstrual pain. This preference stems from the convenience and accessibility of purchasing these products without a prescription. Additionally, the Japanese population is known for valuing self-care and taking proactive measures to manage their health. As a result, there is a high demand for analgesics in pharmacies across the country.

Trends in the market: One notable trend in the Analgesics (Pharmacies) market in Japan is the increasing popularity of natural and herbal remedies. Consumers are becoming more conscious of the ingredients used in their medications and are seeking alternatives that are perceived as safer and more natural. This trend has led to the introduction of a variety of herbal analgesics in the market, which cater to the preferences of health-conscious consumers. Another trend in the market is the rise of online pharmacies. With the increasing use of e-commerce platforms, more consumers are opting to purchase their analgesics online. Online pharmacies offer a wide range of products at competitive prices, making it convenient for consumers to compare and choose the most suitable option. This trend has led to increased competition among pharmacies, both online and offline, and has driven innovation in terms of product offerings and delivery services.

Local special circumstances: One of the unique factors influencing the Analgesics (Pharmacies) market in Japan is the aging population. Japan has one of the highest proportions of elderly citizens in the world, and this demographic group is more likely to experience chronic pain and require regular analgesic medication. As a result, pharmacies in Japan have had to adapt to the specific needs of this population, such as providing specialized products and services tailored to the elderly. Another special circumstance in Japan is the strict regulations surrounding the sale of pharmaceutical products. The Japanese government has implemented stringent quality control measures to ensure the safety and efficacy of analgesics sold in the market. This has created a sense of trust among consumers, who are confident in the quality of the products available in pharmacies.

Underlying macroeconomic factors: The steady growth of the Analgesics (Pharmacies) market in Japan can be attributed to several macroeconomic factors. Firstly, the Japanese economy has been relatively stable in recent years, with a growing middle class and increasing disposable income. This has resulted in higher consumer spending on healthcare products, including analgesics. Furthermore, the healthcare system in Japan is known for its comprehensive coverage and affordable access to medical services. This has encouraged more people to seek medical treatment and purchase analgesics from pharmacies, contributing to the growth of the market. In conclusion, the Analgesics (Pharmacies) market in Japan is experiencing growth due to customer preferences for over-the-counter medications, the popularity of natural remedies, the rise of online pharmacies, the unique circumstances of the aging population, and the underlying macroeconomic factors of a stable economy and comprehensive healthcare system.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.